A study to compare efficacy, safety, and immune response of GME751 and EU-authorized Keytruda in adult participants with untreated metastatic lung cancer

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-506882-70-00

Acronym

CGME751A12301

Enrollment

Registered

2024-04-19

Start date

2024-08-16

Completion date

2025-12-23

Last updated

2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small-cell lung cancer

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany, Romania, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026